Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 22
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease

  • Pérez-López, C.
  • Caballol, Nuria|||0000-0003-3363-3077
  • Buongiorno, M.
  • Ávila Rivera, Maria A.
  • Ariztegui, N.L.
  • López-Manzanares, L.
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Rusiñol, À.B.
  • Gironell, Alexandre|||0000-0003-2109-9030
  • Saúco, M.Á.
  • Gomez, E.F.
  • Pérez-Martínez, D.A.
  • Arroyo, S.E.
  • Martínez, S.M.
  • Mir, Pablo|||0000-0003-1656-302X
  • Salom Juan, J.M.
  • Martínez-Castrillo, J.C.
  • Rodríguez-Molinero, A.
Background: Parkinson's disease (PD) is a significant global health challenge, affecting millions worldwide. This sub-study aims to explore the potential of ambulatory monitoring devices in identifying disease severity and progression in patients. As part of the MOMOPA-EC clinical trial, 156 patients with moderate to severe PD underwent 435 assessments using clinical scales and ambulatory monitoring devices (Parkinson's Holter). This sub-study seeks to establish relations between parameters derived from Holter monitors and clinical severity measures to enhance personalized disease management strategies. Methods: In the MOMOPA-EC trial, 435 patient monitoring sessions were conducted, during which patients wore Parkinson's Holter monitors for a week before completing clinical assessments, including the Unified Parkinson's Disease Rating Scale (UPDRS), Parkinson's Disease Questionnaire (PDQ-39), and Freezing of Gait Questionnaire (FoG-Q). Results: The reports obtained during the monitoring of the patients were classified into three groups based on the greater or lesser gait fluidity (according to the measurements from the Parkinson's Holter). All clinical scales were significantly different in each of these groups, indicating that patients with lower stride fluidity had poorer outcomes across the different clinical scales. Conclusions: The findings of this study underscore the potential of Parkinson's Holters in providing objective data for personalized disease management in PD patients. Integrating such technologies into routine clinical practice could enhance patient care and treatment strategies by offering clinicians objective insights into both disease progression and therapeutic response.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Simplified statistical image reconstruction for X-ray CT with beam-hardening artifact compensation

  • Abella García, Mónica
  • Desco Menéndez, Manuel
  • Vaquero López, Juan José
  • Martínez Sánchez, Cristóbal
CT images are often affected by beam-hardening artifacts due to the polychromatic nature of the X-ray spectra. These artifacts appear in the image as cupping in homogeneous areas and as dark bands between dense regions, such as bones. This paper proposes a simplified statistical reconstruction method for X-ray CT based on Poisson statistics that accounts for the non-linearities caused by beam hardening. The main advantages of the proposed method over previous algorithms is that it avoids the preliminary segmentation step, which can be tricky, especially for low-dose scans, and it does not require knowledge of the whole source spectrum, which is often unknown. Each voxel attenuation is modeled as a mixture of bone and soft tissue by defining density-dependent tissue fractions, maintaining one unknown per voxel. We approximate the energy-dependent attenuation corresponding to different combinations of bone and soft tissue, so called beam-hardening function, with the 1D function corresponding to water plus two parameters that can be tuned empirically. Results on both simulated data with Poisson sinogram noise and two rodent studies acquired with the ARGUSCT system showed a beam hardening reduction (both cupping and dark bands) similar to analytical reconstruction followed by post-processing techniques, but with reduced noise and streaks in cases with low number of projections, as expected for statistical image reconstruction., This work was partially funded by NIH grants R01-HL-098686 and U01 EB018753, by Spanish Ministerio de Economia y Competitividad (projects TEC2013-47270-R and RTC-2014-3028-1) and the Spanish Ministerio de Economia, Industria y Competitividad (projects DPI2016-79075-R AEI/FEDER, UE - Agencia Estatal de Investigación and DTS17/00122 Instituto de Salud Carlos III - FIS), and co-financed by ERDF (FEDER) Funds from the European Commission, “A way of making Europe”. The CNIC is supported by the Spanish Ministerio de Economia, Industria y Competitividad and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505)., Publicado
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Enabling tomography with low-cost C-arm systems

  • Abella García, Mónica
  • Molina Gómez, Claudia de
  • Ballesteros Tenrero, Nerea
  • García Santos, Alba
  • Martínez Álvaro, Alberto
  • García Barquero, Inés
  • Desco Menéndez, Manuel
In scenarios where the use of a Computed Tomography (CT) is difficult, such as during surgery or in the ICU, the use of a C-arm system to generate tomographic information could contribute with interesting additional clinical information. Recent days are seeing the development of the so-called cone-beam CT (CBCT) based on advanced motorized isocentric C-arm systems. To be able to make use of more basic C-arm systems, apart from the geometric non-idealities common to any CBCT, we need to address other difficulties. First, the trajectory of the source-detector pair may differ from a circular path and the system may suffer mechanical strains that modify the relative positions of the source and detector for different projection angles. Second, and more importantly, the exact position of the source and detector elements may not be repeatable for consecutive rotations due to low mechanical precision, thus preventing an accurate geometrical calibration of the system. Finally, the limitation of the angular span and the difficulty of obtaining a high number of projections pose a great challenge to the image reconstruction. In this work, we present a novel method to adapt a standard C-arm, originally designed for planar imaging, to be used as a tomograph. The key parts of the new acquisition protocol are (1) a geometrical calibration method to compensate mechanical inaccuracies that prevent an accurate repetition of source-detector position between acquisitions, and (2) an advanced image reconstruction method able to deal with limited angle data, sparse projections and non-circular trajectories. Both methods exploit surface information from the patient, which can be obtained using a 3D surface scanner. The proposed method was evaluated with two real C-arm systems, based on an image intensifier and a flat panel detector respectively, showing the feasibility of the proposal., This work was supported by Spanish Ministry of Economy and Competitiveness (projects TEC2013-47270-R and RTC-2014-3028-1), Spanish Ministry of Economy, Industry and Competitiveness (projects DPI2016-79075-R AEI/FEDER, UE—Agencia Estatal de Investigación and DTS17/00122 Instituto de Salud Carlos III—FIS), and co-financed by ERDF (FEDER) Funds from the European Commission, “A way of making Europe”. The CNIC is supported by the Spanish Ministry of Economy, Industry and Competitiveness and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Advanced Statistical Techniques for Noninvasive Hyperglycemic States Detection in Mice Using Millimeter-Wave Spectroscopy

  • Moreno Oyervides, Aldo Luis
  • Aguilera Morillo, María del Carmen
  • Larcher Laguzzi, Fernando
  • Krozer, Viktor
  • Acedo Gallardo, Pablo
In this article, we discuss the use of advanced statistical techniques (functional data analysis) in millimeter-wave (mm-wave) spectroscopy for biomedical applications. We employ a W-band transmit-receive unit with a reference channel to acquire spectral data. The choice of the W-band is based on a tradeoff between penetration through the skin providing an upper bound for the frequencies and spectral content across the band. The data obtained are processed using functional principal component logit regression (FPCLoR), which enables to obtain a predictive model for sustained hyperglycemia, typically associated with diabetes. The predictions are based on the transmission data from noninvasive mm-wave spectrometer at W-band. We show that there exists a frequency range most suitable for identification, classification, and prediction of sustained hyperglycemia when evaluating the functional parameter of the functional logit model (β). This allows for the optimization of the spectroscopic instrument in the aim to obtain a compact and potential low-cost noninvasive instrument for hyperglycemia assessment. Furthermore, we also demonstrate that the statistical tools alleviate the problem of calibration, which is a serious obstacle in similar measurements at terahertz and IR frequencies.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

XAP-Lab: A software tool for designing flexible X-ray acquisition protocols

  • Martínez, Álvaro
  • García Santos, Alba
  • Ballesteros Tenrero, Nerea
  • Desco Menéndez, Manuel
  • Abella García, Mónica
Background and Objective:the availability of digital X-ray detectors, together with the development of new robotized hardware and reconstruction algorithms, opens the opportunity to provide 3D capabilities with conventional radiology systems. This would be based on the acquisition of a limited number of projections with non-standard geometrical configurations. The versatility of these techniques is enormous, enabling the introduction of tomography in situations where a CT system is hardly available, such as during surgery or in an ICU, or in which a reduction of radiation dose is key, as in pediatrics. Computer simulations are a valuable tool to explore these possibilities before their actual implementation on real systems. Existing software tools generally simulate only standard acquisition protocols, such as cone-beam with circular trajectory, thus not allowing the users to evaluate more sophisticated projection geometries. The goal of this work is to design a simulation tool that enables the design of acquisition protocols with flexible projection geometries...., This work was supported by Spanish Ministerio de Economia y Competitividad (projects TEC2013-47270-R and RTC-2014-3028-1), Spanish Ministerio de Economia, Industria y Competitividad (projects DPI2016-79075-R AEI/FEDER, UE - Agencia Estatal de Investigación and DTS17/00122 Instituto de Salud Carlos III - FIS), and co-financed by ERDF (FEDER) Funds from the European Commission, “A way of making Europe”. The CNIC is supported by the Spanish Ministerio de Economia, Industria y Competitividad and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).
Repisalud
Publicación Artículo científico (JournalArticle)

Clinical Validation of a 3-Dimensional Ultrafast Cardiac Magnetic Resonance Protocol Including Single Breath-Hold 3-Dimensional Sequences.

  • Gómez-Talavera, Sandra
  • Fernandez-Jimenez, Rodrigo
  • Fuster, Valentin
  • Nothnagel, Nils D
  • Kouwenhoven, Marc
  • Clemence, Matthew
  • García-Lunar, Inés
  • Gómez-Rubín, María C
  • Navarro, Felipe
  • Pérez-Asenjo, Braulio
  • Fernández-Friera, Leticia
  • Calero, María J
  • Orejas, Miguel
  • Cabrera, José Ángel
  • Desco, Manuel
  • Pizarro, Gonzalo
  • Ibáñez, Borja
  • Sánchez-González, Javier
  • Nothnagel, Nils D.
  • Gómez-Rubín, María C.
  • Calero, María J.
  • Cabrera, José Ángel
This study sought to clinically validate a novel 3-dimensional (3D) ultrafast cardiac magnetic resonance (CMR) protocol including cine (anatomy and function) and late gadolinium enhancement (LGE), each in a single breath-hold. CMR is the reference tool for cardiac imaging but is time-consuming. A protocol comprising isotropic 3D cine (Enhanced sensitivity encoding [SENSE] by Static Outer volume Subtraction [ESSOS]) and isotropic 3D LGE sequences was compared with a standard cine+LGE protocol in a prospective study of 107 patients (age 58 ± 11 years; 24% female). Left ventricular (LV) mass, volumes, and LV and right ventricular (RV) ejection fraction (LVEF, RVEF) were assessed by 3D ESSOS and 2D cine CMR. LGE (% LV) was assessed using 3D and 2D sequences. Three-dimensional and LGE acquisitions lasted 24 and 22 s, respectively. Three-dimensional and LGE images were of good quality and allowed quantification in all cases. Mean LVEF by 3D and 2D CMR were 51 ± 12% and 52 ± 12%, respectively, with excellent intermethod agreement (intraclass correlation coefficient [ICC]: 0.96; 95% confidence interval [CI]: 0.94 to 0.97) and insignificant bias. Mean RVEF 3D and 2D CMR were 60.4 ± 5.4% and 59.7 ± 5.2%, respectively, with acceptable intermethod agreement (ICC: 0.73; 95% CI: 0.63 to 0.81) and insignificant bias. Both 2D and 3D LGE showed excellent agreement, and intraobserver and interobserver agreement were excellent for 3D LGE. ESSOS single breath-hold 3D CMR allows accurate assessment of heart anatomy and function. Combining ESSOS with 3D LGE allows complete cardiac examination in <1 min of acquisition time. This protocol expands the indication for CMR, reduces costs, and increases patient comfort.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Analysis of Exosome Transfer in Mammalian Cells by Fluorescence Recovery after Photobleaching

  • González-King, Hernán
  • Garcia, Nahuel A.
  • Ciria, María
  • Gascón, Sandra T.
  • Sánchez, Rafael S.
  • Grueso, Helena
  • Gómez, Marta
  • Cava, Vanesa L.
  • Sepúlveda, Pilar
  • Martín-Cabezuelo, Rubén|||0000-0002-5642-4692
[EN] During the course of evolution, prokaryote and eukaryote cells have developed elegant and to some extent analogous strategies to communicate with each other and to adapt to their surrounding environment. Eukaryotic cells communicate with each other through direct interaction via juxtracrine signaling and/or by secreting soluble factors. These secreted factors can subsequently act on the cell itself (autocrine signaling) or interact with neighboring (paracrine signaling) and distant (endocrine signaling) cells. The transmission of signals between cells and tissues has been traditionally thought to be regulated by a protein-based signaling system. Typically, proteins destined for secretion into the extracellular milieu by exocytosis contain a canonical secretion-targeting sequence (Thery et al., 2002). However, proteins with a non-continuous and stimulus-dependent secretion, proteins that do not contain a canonical secretion-targeting sequence, and species that might be too labile within the extracellular environment (DNA, mRNA, peptides, metabolites, miRNA and other RNA species), can be secreted in small membranous extracellular vesicles (EVs) in a specific manner (Hagiwara et al., 2014). Exosomes represent one broad class of these secreted membrane vesicles with a diameter of 30-130 nm (Cocucci et al., 2009; Thery et al., 2009; Kowal et al., 2014), which are formed inside the secreting cells in endosomal compartments called multivesicular bodies. Molecules loaded into exosomes as well as the intensity of the exosome transfer between cells are important parameters for the subsequent conditioning of recipient cells. Current knowledge on secretion of exosomes and their internalization in recipient cells remains incomplete. It is known that secretion intensity of exosomes varies according to the cellular type and its physiological state (Garcia et al., 2016). Moreover, the different combination of transmembrane proteins on the surface of exosomes that facilitate the adhesion to the cell-extracellular matrix vary the avidity with which a recipient cell captures exosomes (Hoshino et al., 2015). Here, we have developed an in vitro system by which the transfer of exosomes between cells in co-culture can be quantified using FRAP ('Fluorescence Recovery After Photobleaching') technology. This protocol has been used to analyze the effects of exosome transfer of hypoxia inducible factor 1-alpha (HIF-1 alpha) in Mesenchymal Stem Cells (MSC; HIF-MSC)to Human Umbilical Cord Vein Endothelial Cells (HUVEC) (Gonzalez-King et al., 2017)., This work was supported in part by grants from the Instituto de Salud Carlos III (PI16/00107, DTS15/00079, DTS17/0067), RETICS RD16/0011/0004 to PS co-funded by FEDER 'una manera de hacer Europa'. It was also supported by the Regenerative Medicine Program of Instituto de Salud Carlos III and the Valencian Community to Centro de Investigacidn Principe Felipe. H. G-K acknowledges a predoctoral fellowship associated with the Hecatos project (FP7-HEALTH-2013-INNOVATION). This work has been published in Stem Cells, where the protocol was used for the first time (Gonzalez-King et al., 2017). Authors declare no conflict of interest.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Comparative Analysis of Chromatin-Delivered Biomarkers in the Monitoring of Sepsis and Septic Shock: A Pilot Study

  • Beltrán-García, Jesús
  • García-López, Eva M.
  • Carbonell, Nieves
  • Ferreres, José
  • Rodríguez-Gimillo, María
  • Garcés, Concepción
  • Pallardó, Federico V.
  • García-Giménez, José L.
  • Montoya, Ángel
  • Romá-Mateo, Carlos
  • Manclus Ciscar, Juan José|||0000-0001-6720-1534
[EN] Sepsis management remains one of the most important challenges in modern clinical practice. Rapid progression from sepsis to septic shock is practically unpredictable, hence the critical need for sepsis biomarkers that can help clinicians in the management of patients to reduce the proba-bility of a fatal outcome. Circulating nucleoproteins released during the inflammatory response to infection, including neutrophil extracellular traps, nucleosomes, and histones, and nuclear pro-teins like HMGB1, have been proposed as markers of disease progression since they are related to inflammation, oxidative stress, endothelial damage, and impairment of the coagulation response, among other pathological features. The aim of this work was to evaluate the actual potential for decision making/outcome prediction of the most commonly proposed chromatin-related bi-omarkers (i.e., nucleosomes, citrullinated H3, and HMGB1). To do this, we compared different ELISA measuring methods for quantifying plasma nucleoproteins in a cohort of critically ill pa-tients diagnosed with sepsis or septic shock compared to nonseptic patients admitted to the inten-sive care unit (ICU), as well as to healthy subjects. Our results show that all studied biomarkers can be used to monitor sepsis progression, although they vary in their effectiveness to separate sepsis and septic shock patients. Our data suggest that HMGB1/citrullinated H3 determination in plasma is potentially the most promising clinical tool for the monitoring and stratification of septic patients., This activity received funding from the European Institute of Innovation and Technology (EIT). This body of the European Union receives support from the European Union's Horizon 2020 research and innovation program. C.R-M. thanks GVA for starting grant (GV/2018/127) and Spanish Ministry of Science and Innovation for research project (PID2020-119127RA-I00); J.B-G thanks ISCIII, AES2018 for iPFIS fellowship (IFI18/00015) and GVA for APOTI fellowship (APOTIP/2017/012); CG thanks Spanish Ministry of Universities for fellowship FPU18/03969; J.L.G-G and F.V.P thank INCLIVA, GVA and AES2016 and AES2019 (ISCIII) for starting grant (GV/2014/132), project PI16/01036 and PI19/00994 and project DTS17/00132 (co-financed by the ERDF). The project leading to these results has received funding from "la Caixa" Foundation (ID 100010434), under agreement CI18-0009. C.R-M., F.V.P. and A.M. thank Grand Challenges Canada. : We want to particularly acknowledge the patients and the INCLIVA Biobank (PT17/0015/0049; B.000768 ISCIII) integrated in the Valencian Biobanking Network and the Spanish National Biobanks Network for their collaboration.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Early, Non-Invasive Sensing of Sustained Hyperglycemia in Mice Using Millimeter-Wave Spectroscopy

  • Moreno-Oyervides, Aldo
  • Martín-Mateos, Pedro
  • Ulisse, Giacomo
  • Arriba, María C.
  • Durban, María
  • Del Rio, Marcela
  • Larcher, Fernando
  • Krozer, Viktor
  • Acedo, Pablo
  • Aguilera-Morillo, M. Carmen|||0000-0003-1027-9773
[EN] Diabetes is a very complex condition affecting millions of people around the world. Its occurrence, always accompanied by sustained hyperglycemia, leads to many medical complications that can be greatly mitigated when the disease is treated in its earliest stage. In this paper, a novel sensing approach for the early non-invasive detection and monitoring of sustained hyperglycemia is presented. The sensing principle is based on millimeter-wave transmission spectroscopy through the skin and subsequent statistical analysis of the amplitude data. A classifier based on functional principal components for sustained hyperglycemia prediction was validated on a sample of twelve mice, correctly classifying the condition in diabetic mice. Using the same classifier, sixteen mice with drug-induced diabetes were studied for two weeks. The proposed sensing approach was capable of assessing the glycemic states at different stages of induced diabetes, providing a clear transition from normoglycemia to hyperglycemia typically associated with diabetes. This is believed to be the first presentation of such evolution studies using non-invasive sensing. The results obtained indicate that gradual glycemic changes associated with diabetes can be accurately detected by non-invasively sensing the metabolism using a millimeter-wave spectral sensor, with an observed temporal resolution of around four days. This unprecedented detection speed and its non-invasive character could open new opportunities for the continuous control and monitoring of diabetics and the evaluation of response to treatments (including new therapies), enabling a much more appropriate control of the condition., This research was supported in part by the Spanish Ministry of Economy and Competitiveness through the project TEC2017-86271-R and the Instituto de Salud Carlos III (Spain) through the grant DTS17/00135. Thanks to the Consejo Nacional de Ciencia y Tecnología de México (CONACYT) for financially supporting the doctoral education of Aldo M-O (PhD. Grant). Viktor Krozer is thankful for partial financial support in the frame of the Chairs of Excellence program of the Universidad Carlos III, Madrid, Spain. This research was partially supported by Project MTM2017-88708-P from Ministerio de Economía y Competitividad, FEDER funds, Project IJCI-2017-34038 from Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades and the Spanish Ministry of Economy and Competitiveness MTM2014-52184-P.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Integrative metabolic pathway analysis reveals novel therapeutic targets in osteoarthritis

  • Rocha Loureda, Beatriz
  • Cillero-Pastor, B.
  • Eijkel, Gert
  • Calamia, Valentina
  • Fernández-Puente, Patricia
  • Paine, Martin R.L.
  • Ruiz-Romero, Cristina
  • Heeren, Ron M.A.
  • Blanco García, Francisco J
Data availability: The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (https://www.ebi.ac.uk/pride/archive/projects/PXD012879) with the dataset identifier PXD012879 and the project name of MSCs OA SILAC Mass spectrometry imaging, [Abstract] In osteoarthritis (OA), impairment of cartilage regeneration can be related to a defective chondrogenic differentiation of mesenchymal stromal cells (MSCs). Therefore, understanding the proteomic- and metabolomic-associated molecular events during the chondrogenesis of MSCs could provide alternative targets for therapeutic intervention. Here, a SILAC-based proteomic analysis identified 43 proteins related with metabolic pathways whose abundance was significantly altered during the chondrogenesis of OA human bone marrow MSCs (hBMSCs). Then, the level and distribution of metabolites was analyzed in these cells and healthy controls by matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), leading to the recognition of characteristic metabolomic profiles at the early stages of differentiation. Finally, integrative pathway analysis showed that UDP-glucuronic acid synthesis and amino sugar metabolism were downregulated in OA hBMSCs during chondrogenesis compared with healthy cells. Alterations in these metabolic pathways may disturb the production of hyaluronic acid (HA) and other relevant cartilage extracellular matrix (ECM) components. This work provides a novel integrative insight into the molecular alterations of osteoarthritic MSCs and potential therapeutic targets for OA drug development through the enhancement of chondrogenesis., This work has been funded by Fondo Investigación Sanitaria-Spain (grant numbers PI14/01707, PI16/02124, PI17/00404, DTS17/00200, CIBER-CB06/01/0040 and RETIC-RIER-RD12/0009/0018), a part of the National Plan for Scientific Program Development and Technological Innovation 2013–2016, funded by the ISCIII-General Subdirection of Assessment and Promotion of Research - European Regional Development Fund (FEDER) “A way of making Europe.” The Proteomics Unit of GIR belongs to ProteoRed, PRB2- ISCIII (grant number PT17/0019/0014). B.R. is supported by Xunta de Galicia (IN606B-2016/004). The research was partially performed within the M4I research program, financially supported by the Dutch Province of Limburg as part of the “LINK” program, Xunta de Galicia; IN606B-2016/004, https://www.ebi.ac.uk/pride/archive/projects/PXD012879
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Antiviral and Antiproliferative Potential of Marine Organisms from the Yucatan Peninsula, Mexico

  • Pech-Puch, Dawrin
  • Berastegui-Cabrera, Judith
  • Pérez Povedano, Mar Anabel
  • Villegas-Hernández, Harold
  • Guillén-Hernández, Sergio
  • Cautain, Bastien
  • Reyes, Fernando
  • Pachón, Jerónimo
  • Gómez, Patricia
  • Rodríguez, Jaime
  • Jiménez, Carlos
  • Sánchez Céspedes, Javier
[Abstract] Viral infections are one of the main human health problems in recent decades and the cancer remains one of the most lethal diseases worldwide. The development of new antiviral drugs for the treatment of human adenovirus (HAdV) infections continues to be a challenging goal for medicinal chemistry. There is no specific antiviral drug approved to treat infections caused by HAdV so far and the off-label treatments currently available show great variability in their effectiveness. In relation to cancer, most of the available drugs are designed to act on specific targets by altering the activity of involved transporters and genes. Taking into account the high antiviral and antiproliferative activity against tumor cell lines displayed by some marine natural products reported in the literature, sixty five marine organisms were selected: 51 sponges (Porifera), 13 ascidians (Chordata), and 1 gorgonian (Cnidaria), collected from Yucatan Peninsula, Mexico, to evaluate their antiviral activity against human adenovirus type 5 (HAdV5) and their anticancer properties against five human tumor cell lines, namely human lung carcinoma (A549), human skin melanoma (A2058), hepatocyte carcinoma (HepG2), breast adenocarcinoma (MCF7), and pancreas carcinoma (MiaPaca-2). Eleven extracts displayed anti-HAdV activity being the organic extracts of Dysidea sp., Agelas citrina, Chondrilla sp., Spongia tubulifera, and Monanchora arbuscula the five most active ones. On the other hand, 24 extracts showed antiproliferative activity against at least one tumor cell line, being the extracts of the ascidian Eudistoma amanitum and the sponge Haliclona (Rhizoniera) curacaoensis the most active ones. This work constitutes the first wide antiviral and antiproliferative screening report of extracts from the marine sponges, ascidians, and a gorgonian collected from the Yucatan Peninsula, Mexico., This work was supported by Grants RTI2018-093634-B-C22 and RTC-2016-4611-1 (AEI/FEDER, EU) from the State Agency for Research (AEI) of Spain, both co-funded by the FEDER Programme from the European Union, BLUEBIOLAB (0474_BLUEBIOLAB_1_E), Programme INTERREG V A of Spain-Portugal (POCTEP). The study was also funded by projects GRC2018/039 and Agrupación Estratégica CICA-INIBIC ED431E 2018/03 (Consejería de Educación, Universidad y Formación Profesional de la Junta de Galicia) from the Xunta de Galicia (autonomous government of the region). DP-P received a fellowship from the program National Council of Science and Technology (CONACYT) of Mexico and the Secretariat of Research, Innovation and Higher Education (SIIES) of Yucatan (Mexico). Also supported by Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0009) – co-financed by “A way to achieve Europe” ERDF, the Instituto de Salud Carlos III, Proyectos de Desarrollo Tecnológico en Salud (DTS17/00130 and PI18/01191), and the Spanish Adenovirus Network (AdenoNet, BIO2015/68990-REDT). JS-C is a researcher belonging to the program “Nicolás Monardes” (C-0059-2018), Servicio Andaluz de Salud, Junta de Andalucía, Spain. The antiproliferative studies were financed with internal funds from Fundación MEDINA, Xunta de Galicia; 0474_BLUEBIOLAB_1_E, Xunta de Galicia; GRC2018/039, Xunta de Galicia; ED431E 2018/03, Junta de Andalucía; C-0059-2018
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

  • Lourido Salas, Lucía María
  • Balboa-Barreiro, Vanesa
  • Ruiz-Romero, Cristina
  • Rego-Pérez, I.
  • Camacho Encina, María
  • Paz González, Rocío
  • Calamia, Valentina
  • Oreiro Villar, Natividad
  • Nilsson, Peter
  • Blanco García, Francisco J
The Osteoarthritis Initiative (OAI) is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; and GlaxoSmithKline. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This work has been supported by grants from Fondo Investigación Sanitaria (PI16/02124, PI17/00404, PI19/01206, DTS17/00200, CIBER-CB06/01/0040 and RETIC-RIER-RD16/0012/0002), integrated in the National Plan for Scientific Program, Development and Technological Innovation 2013–2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) “A way of making Europe”. This study has been also supported by grants IN607A2017/11, IN607D2020/10 and AE CICA-INIBIC (ED431E 2018/03) from Xunta de Galicia. The Proteomics Unit of GIR belongs to ProteoRed, PRB3- ISCIII (PT17/0019/0014). L.L. is supported by Xunta de Galicia (IN606B-2016/2005) and Contrato Sara Borrell (CD19/00229) Fondo de Investigación Sanitaria, ISCIII. I.R.P. is supported by Contrato Miguel Servet-II Fondo de Investigación Sanitaria (CPII17/00026). This work was also supported by the KTH Center for Applied Precision Medicine funded by the Ehrling Persson foundation, as well as the Human Protein Atlas project funded by Knut and Alice Wallenberg Foundation, Xunta de Galicia; IN607A2017/11, Xunta de Galicia; IN607D2020/10, Xunta de Galicia; ED431E 2018/03, Xunta de Galicia; IN606B-2016/2005
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microdosimetric Spectra Measurements on a Clinical Carbon Beam at Nominal Therapeutic Fluence Rate With Silicon Cylindrical Microdosimeters

  • Prieto-Pena, Juan
  • Gomez, Faustino
  • Fleta, Celeste
  • Guardiola, Consuelo
  • Pellegrini, Giulio
  • Donetti, Marco
  • Giordanengo, Simona
  • Gonzalez-Castano, Diego M.
  • Pardo-Montero, Juan
The use of protons and heavy ions for the treatment of tumors is increasing since it provides a better relative biological effectiveness (RBE) than traditional radiotherapy. Accurate knowledge of the energy deposition at submicrometric scales is paramount for RBE characterization. This paper shows the latest version of the silicon cylindrical microdosimeter array developed by the Instituto de Microelectrónica de Barcelona, Centro Nacional de Microelectrónica (IMB-CNM, Spain). The detector consists of a matrix of 11 × 11 cylindrical sensitive unit cells with individual readout etched within the silicon substrate available in different diameters and pitches between detectors. The detector employed in this paper had a diameter of 15μ, a pitch of 200μ, and a thickness of 5.5μ. The detectors were tested in the clinical facilities of Fondazione Centro Nazionale di Adronterapia Oncologica (CNAO) (Pavia, Italy) employing a 12C pencil beam at a therapeutic beam fluence rate. Microdosimetric spectra of lineal energy were measured in different depths of polymethyl methacrylate (PMMA) up to the Bragg peak. Results were then compared with Monte Carlo simulations using the FLUKA particle transport code, showing an excellent agreement between experimental and simulated microdosimetric distributions even at the high fluence rates associated with clinical beams., Manuscript received May 7, 2019; accepted June 4, 2019. Date of publication June 6, 2019; date of current version July 16, 2019. The works of J. Prieto-Pena, F. Gómez, and D. M. González-Castaño were supported by the Spanish MINECO Project under Grant DPI2014-57645-R. The work of J. Prieto-Pena was supported by a Predoctoral Fundación Barrié Grant. The work of J. Pardo-Montero was supported by the Instituto de Salud Carlos III under Grant CPII17/00028, Grant PI17/01428, and Grant DTS17/00123., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease

  • Pérez-López, Carlos
  • Caballol, Nuria
  • Buongiorno, Mariateresa
  • Ávila Rivera, María Asunción
  • López-Ariztegui, Nuria
  • López-Manzanares, Lydia
  • Hernández-Vara, Jorge
  • Bayes Rusiñol, Àngels
  • Carreró, Alexandre Gironell
  • Álvarez-Sauco, María
  • Franquet Gómez, Elisabet
  • Pérez-Martínez, David A.
  • Escalante Arroyo, Sonia
  • Martí Martínez, Silvia
  • Mir, Pablo
  • Salom, José María
  • Martínez-Castrillo, Juan Carlos
  • Rodríguez-Molinero, Alejandro
[Trial registration] NCT04176302 Registered 18 November 2019, https://clinicaltrials.gov/show/NCT04176302., [Background] Parkinson’s disease (PD) is a significant global health challenge, affecting millions worldwide. This sub-study aims to explore the potential of ambulatory monitoring devices in identifying disease severity and progression in patients. As part of the MOMOPA-EC clinical trial, 156 patients with moderate to severe PD underwent 435 assessments using clinical scales and ambulatory monitoring devices (Parkinson’s Holter). This sub-study seeks to establish relations between parameters derived from Holter monitors and clinical severity measures to enhance personalized disease management strategies. Methods: In the MOMOPA-EC trial, 435 patient monitoring sessions were conducted, during which patients wore Parkinson’s Holter monitors for a week before completing clinical assessments, including the Unified Parkinson’s Disease Rating Scale (UPDRS), Parkinson’s Disease Questionnaire (PDQ-39), and Freezing of Gait Questionnaire (FoG-Q). Results: The reports obtained during the monitoring of the patients were classified into three groups based on the greater or lesser gait fluidity (according to the measurements from the Parkinson’s Holter). All clinical scales were significantly different in each of these groups, indicating that patients with lower stride fluidity had poorer outcomes across the different clinical scales. Conclusions: The findings of this study underscore the potential of Parkinson’s Holters in providing objective data for personalized disease management in PD patients. Integrating such technologies into routine clinical practice could enhance patient care and treatment strategies by offering clinicians objective insights into both disease progression and therapeutic response., This work is supported by the Instituto de Salud Carlos III [DTS17/00195], the “A way to make Europe” European Fund for Regional Development, and AbbVie S.L.U., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Prediction of the response to antiangiogenic sunitinib therapy by non-invasive hybrid diffuse optics in renal cell carcinoma

  • Mireles, Miguel
  • Jimenez-Valerio, Gabriela
  • Morales Dalmau, Jordi
  • Johansson, Johannes D.
  • Martínez-Lozano, Mar
  • Vidal-Rosas, Ernesto E.
  • Navarro-Perez, Valentí
  • Busch, David R.
  • Casanovas, Oriol
  • Durduran, Turgut
  • Vilches, Clara
In this work, broadband diffuse reflectance spectroscopy (DRS) and diffuse correlation spectroscopy (DCS) were used to quantify deep tissue hemodynamics in a patient-derived orthotopic xenograft mouse model of clear cell renal cancer undergoing antiangiogenic treatment. A cohort of twenty-two mice were treated with sunitinib and compared to thirteen control untreated mice, and monitored by DRS/DCS. A reduction in total hemoglobin concentration (THC, p = 0.03), oxygen saturation (SO2, p = 0.03) and blood flow index (BFI, p = 0.02) was observed over the treatment course. Early changes in tumor microvascular blood flow and total hemoglobin concentration were correlated with the final microvessel density (p = 0.014) and tumor weight (p = 0.024), respectively. Higher pre-treatment tumor microvascular blood flow was observed in non-responder mice with respect to responder mice, which was statistically predictive of the tumor intrinsic resistance (p = 0.01). This hybrid diffuse optical technique provides a method for predicting tumor intrinsic resistance to antiangiogenic therapy and could be used as predictive biomarker of response to antiangiogenic therapies in pre-clinical models., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Prediction of the response to antiangiogenic sunitinib therapy by non-invasive hybrid diffuse optics in renal cell carcinoma

  • Mireles, Miguel
  • Jimenez-Valerio, Gabriela
  • Morales Dalmau, Jordi
  • Johansson, Johannes D.
  • Martínez-Lozano, Mar
  • Vidal-Rosas, Ernesto E.
  • Navarro-Perez, Valentí
  • Busch, David R.
  • Casanovas, Oriol
  • Durduran, Turgut
  • Vilches, Clara
In this work, broadband diffuse reflectance spectroscopy (DRS) and diffuse correlation spectroscopy (DCS) were used to quantify deep tissue hemodynamics in a patient-derived orthotopic xenograft mouse model of clear cell renal cancer undergoing antiangiogenic treatment. A cohort of twenty-two mice were treated with sunitinib and compared to thirteen control untreated mice, and monitored by DRS/DCS. A reduction in total hemoglobin concentration (THC, p = 0.03), oxygen saturation (SO2, p = 0.03) and blood flow index (BFI, p = 0.02) was observed over the treatment course. Early changes in tumor microvascular blood flow and total hemoglobin concentration were correlated with the final microvessel density (p = 0.014) and tumor weight (p = 0.024), respectively. Higher pre-treatment tumor microvascular blood flow was observed in non-responder mice with respect to responder mice, which was statistically predictive of the tumor intrinsic resistance (p = 0.01). This hybrid diffuse optical technique provides a method for predicting tumor intrinsic resistance to antiangiogenic therapy and could be used as predictive biomarker of response to antiangiogenic therapies in pre-clinical models., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits

  • Moserle, Lidia
  • Pons, Roser
  • Martínez-Lozano, Mar
  • Jiménez-Valerio, Gabriela A
  • Vidal, August
  • Suárez Rodríguez, Cristina
  • Trilla Herrera, Enric
  • Jiménez Flores, José Antonio
  • Torres Ramirez, Inés de
  • Carles Galceran, Joan
Antiangiogènica; Resistència al càncer; Inducció de metàstasi, Antiangiogénico; Resistencia al cáncer; Inducción de metástasis, Antiangiogenic; Cancer resistance; Induction of metastasis, An open debate in antiangiogenic therapies is about their consequence on tumor invasiveness and metastasis, which is undoubtedly relevant for patients currently treated with antiangiogenics, such as renal cell carcinoma patients. To address, this we developed an extensive series of 27 patient biopsy-derived orthotopic xenograft models (Ren-PDOX) that represent inter-patient heterogeneity. In specific tumors, antiangiogenics produced increased invasiveness and metastatic dissemination, while in others aggressiveness remained unchanged. Mechanistically, species-discriminative RNA sequencing identified a tumor cell-specific differential expression profile associated with tumor progression and aggressivity in TCGA RCC patients. Gene filtering using an invasion-annotated patient series pinpointed two candidate genes, of which ALDH1A3 differentiated the pro-invasive subtype of Ren-PDOXs. Validation in an independent series of 15 antiangiogenic-treated patients confirmed that pre-treatment ALDH1A3 can significantly discriminate patients with pro-aggressive response upon treatment. Overall, results confirm that effects of antiangiogenic drugs on tumor invasion and metastasis are heterogeneous and may profoundly affect the natural progression of tumors and promote malignancy. Furthermore, we identify a specific molecular biomarker that could be used to select patients that better benefit from treatment., This work was supported by research grants from ERC (ERC-StG-281830) EU-FP7, Ministerio de Ciencia, Innovación y Universidades, through the Retos Investigación grant, Refs: SAF2016-79347-R and PID2019-107557RB-I00/AEI/10.13039/501100011033, ISCIII Spain (AES, DTS17/00194), AGAUR-Generalitat de Catalunya (2017SGR771), Marató de TV3 (201910-30-31-32) and Italian Association for Cancer Research (AIRC) IG#14032, DOR - University of Padova, IOV 5x1000 fund. We thank CERCA Programme / Generalitat de Catalunya for institutional support.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging

  • Piñeiro-Hermida, Sergio|||0000-0002-8915-5687
  • Autilio, Chiara
  • Martínez, Paula|||0000-0002-4655-5672
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
  • Pérez-Gil, Jesús
  • Blasco, María A.|||0000-0002-4211-233X
Here, we show that physiological aging in mice leads to degenerative and fibrotic-like pathologies in the lung and that telomerase gene therapy prevents the onset of these pathologies. Our findings highlight telomerase activation as a potential therapeutic strategy for lung degenerative pathologies associated with aging. Short/dysfunctional telomeres are at the origin of idiopathic pulmonary fibrosis (IPF) in patients mutant for telomere maintenance genes. However, it remains unknown whether physiological aging leads to short telomeres in the lung, thus leading to IPF with aging. Here, we find that physiological aging in wild-type mice leads to telomere shortening and a reduced proliferative potential of alveolar type II cells and club cells, increased cellular senescence and DNA damage, increased fibroblast activation and collagen deposits, and impaired lung biophysics, suggestive of a fibrosis-like pathology. Treatment of both wild-type and telomerase-deficient mice with telomerase gene therapy prevented the onset of lung profibrotic pathologies. These findings suggest that short telomeres associated with physiological aging are at the origin of IPF and that a potential treatment for IPF based on telomerase activation would be of interest not only for patients with telomerase mutations but also for sporadic cases of IPF associated with physiological aging.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prognostic Biomarkers in Endometrial Cancer, A Systematic Review and Meta-Analysis

  • Coll de la Rubia, Eva|||0000-0001-6709-7554
  • Martinez-Garcia, Elena|||0000-0003-2547-7916
  • Dittmar, Gunnar|||0000-0003-3647-8623
  • Gil-Moreno, Antonio|||0000-0003-1106-5590
  • Cabrera Díaz, Silvia|||0000-0002-3164-6686
  • Colás Ortega, Eva|||0000-0003-0302-4828
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its mortality is directly associated with the presence of poor prognostic factors driving tumor recurrence. Stratification systems are based on few molecular, and mostly clinical and pathological parameters, but these systems remain inaccurate. Therefore, identifying prognostic EC biomarkers is crucial for improving risk assessment pre- and postoperatively and to guide treatment decisions. This systematic review gathers all protein biomarkers associated with clinical prognostic factors of EC, recurrence and survival. Relevant studies were identified by searching the PubMed database from 1991 to February 2020. A total number of 398 studies matched our criteria, which compiled 255 proteins associated with the prognosis of EC. MUC16, ESR1, PGR, TP53, WFDC2, MKI67, ERBB2, L1CAM, CDH1, PTEN and MMR proteins are the most validated biomarkers. On the basis of our meta-analysis ESR1, TP53 and WFDC2 showed potential usefulness for predicting overall survival in EC. Limitations of the published studies in terms of appropriate study design, lack of high-throughput measurements, and statistical deficiencies are highlighted, and new approaches and perspectives for the identification and validation of clinically valuable EC prognostic biomarkers are discussed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson's symptoms against other clinical monitoring methods, study protocol

  • Rodríguez-Molinero, Alejandro|||0000-0002-9678-2654
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Miñarro, Antonio
  • Pérez-López, Carlos|||0000-0001-7400-4360
  • Bayés, Àngels|||0000-0001-9542-804X
  • Martínez-Castrillo, Juan Carlos|||0000-0001-7744-6850
  • Pérez-Martínez, David Andrés|||0000-0001-5587-0415
In recent years, multiple studies have aimed to develop and validate portable technological devices capable of monitoring the motor complications of Parkinson's disease patients (Parkinson's Holter). The effectiveness of these monitoring devices for improving clinical control is not known. This is a single-blind, cluster-randomised controlled clinical trial. Neurologists from Spanish health centres will be randomly assigned to one of three study arms (1:1:1): (a) therapeutic adjustment using information from a Parkinson's Holter that will be worn by their patients for 7 days, (b) therapeutic adjustment using information from a diary of motor fluctuations that will be completed by their patients for 7 days and (c) therapeutic adjustment using clinical information collected during consultation. It is expected that 162 consecutive patients will be included over a period of 6 months. The primary outcome is the efficiency of the Parkinson's Holter compared with traditional clinical practice in terms of Off time reduction with respect to the baseline (recorded through a diary of motor fluctuations, which will be completed by all patients). As secondary outcomes, changes in variables related to other motor complications (dyskinesia and freezing of gait), quality of life, autonomy in activities of daily living, adherence to the monitoring system and number of doctor-patient contacts will be analysed. The noninferiority of the Parkinson's Holter against the diary of motor fluctuations in terms of Off time reduction will be studied as the exploratory objective. Ethics and dissemination approval for this study has been obtained from the Hospital Universitari de Bellvitge Ethics Committee. The results of this study will inform the practical utility of the objective information provided by a Parkinson's Holter and, therefore, the convenience of adopting this technology in clinical practice and in future clinical trials. We expect public dissemination of the results in 2022.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of the Results of a Parkinson's Holter Monitor With Patient Diaries, in Real Conditions of Use, A Sub-analysis of the MoMoPa-EC Clinical Trial

  • Pérez-López, Carlos|||0000-0001-7400-4360
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Caballol, Nuria|||0000-0003-3363-3077
  • Bayés, Àngels|||0000-0001-9542-804X
  • Buongiorno, María Teresa
  • Lopez-Ariztegui, Núria
  • Gironell, Alexandre|||0000-0003-2109-9030
  • López-Sánchez, José
  • Martínez-Castrillo, Juan Carlos|||0000-0001-7744-6850
  • Álvarez Sauco, María
  • López Manzanares, Lydia|||0000-0003-4615-4542
  • Escalante, Sonia|||0000-0001-8931-1400
  • Pérez-Martínez, David Andrés|||0000-0001-5587-0415
  • Rodríguez-Molinero, Alejandro|||0000-0002-9678-2654
Background: For specialists in charge of Parkinson's disease (PD), one of the most time-consuming tasks of the consultations is the assessment of symptoms and motor fluctuations. This task is complex and is usually based on the information provided by the patients themselves, which in most cases is complex and biased. In recent times, different tools have appeared on the market that allow automatic ambulatory monitoring. The MoMoPa-EC clinical trial (NCT04176302) investigates the effect of one of these tools-Sense4Care's STAT-ON-can have on routine clinical practice. In this sub-analysis the agreement between the Hauser diaries and the STAT-ON sensor is analyzed. Methods: Eighty four patients from MoMoPa-EC cohort were included in this sub-analysis. The intraclass correlation coefficient was calculated between the patient diary entries and the sensor data. Results: The intraclass correlation coefficient of both methods was 0.57 (95% CI: 0.3-0.73) for the OFF time (%), 0.48 (95% CI: 0.17-0.68) for the time in ON (%), and 0.65 (95% CI%: 0.44-0.78) for the time with dyskinesias (%). Furthermore, the Spearman correlations with the UPDRS scale have been analyzed for different parameters of the two methods. The maximum correlation found was -0.63 (p < 0.001) between Mean Fluidity (one of the variables offered by the STAT-dON) and factor 1 of the UPDRS. Conclusion: This sub-analysis shows a moderate concordance between the two tools, it is clearly appreciated that the correlation between the different UPDRS indices is better with the STAT-ON than with the Hauser diary. Trial Registration: https://clinicaltrials.gov/show/NCT04176302 (NCT04176302).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits

  • Moserle, Lidia
  • Pons, Roser
  • Martínez-Lozano, Mar
  • Jiménez-Valerio, Gabriela A
  • Vidal, August
  • Suárez Rodríguez, Cristina
  • Trilla Herrera, Enric
  • Jiménez Flores, José Antonio
  • Torres Ramirez, Inés de
  • Carles Galceran, Joan
Antiangiogènica; Resistència al càncer; Inducció de metàstasi, Antiangiogénico; Resistencia al cáncer; Inducción de metástasis, Antiangiogenic; Cancer resistance; Induction of metastasis, An open debate in antiangiogenic therapies is about their consequence on tumor invasiveness and metastasis, which is undoubtedly relevant for patients currently treated with antiangiogenics, such as renal cell carcinoma patients. To address, this we developed an extensive series of 27 patient biopsy-derived orthotopic xenograft models (Ren-PDOX) that represent inter-patient heterogeneity. In specific tumors, antiangiogenics produced increased invasiveness and metastatic dissemination, while in others aggressiveness remained unchanged. Mechanistically, species-discriminative RNA sequencing identified a tumor cell-specific differential expression profile associated with tumor progression and aggressivity in TCGA RCC patients. Gene filtering using an invasion-annotated patient series pinpointed two candidate genes, of which ALDH1A3 differentiated the pro-invasive subtype of Ren-PDOXs. Validation in an independent series of 15 antiangiogenic-treated patients confirmed that pre-treatment ALDH1A3 can significantly discriminate patients with pro-aggressive response upon treatment. Overall, results confirm that effects of antiangiogenic drugs on tumor invasion and metastasis are heterogeneous and may profoundly affect the natural progression of tumors and promote malignancy. Furthermore, we identify a specific molecular biomarker that could be used to select patients that better benefit from treatment., This work was supported by research grants from ERC (ERC-StG-281830) EU-FP7, Ministerio de Ciencia, Innovación y Universidades, through the Retos Investigación grant, Refs: SAF2016-79347-R and PID2019-107557RB-I00/AEI/10.13039/501100011033, ISCIII Spain (AES, DTS17/00194), AGAUR-Generalitat de Catalunya (2017SGR771), Marató de TV3 (201910-30-31-32) and Italian Association for Cancer Research (AIRC) IG#14032, DOR - University of Padova, IOV 5x1000 fund. We thank CERCA Programme / Generalitat de Catalunya for institutional support.